Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation

NCT00137579 is registered in ClinicalTrials.gov with Catalan Institute of Health as lead sponsor.

NCT NCT00137579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00137579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Simple Blind, 2-Parallel Groups Randomized Trial to Evaluate the Safety and Effectiveness of the Intramuscular Vs Subcutaneous Route for the Administration of the Anti-Flu Vaccine in Patients Receiving Oral Anticoagulation
Lead sponsor
Catalan Institute of Health
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2003
Completion date
May 31, 2004
Enrollment
216
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza